首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum
【24h】

Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum

机译:疾病相关突变导致内质网髓磷脂蛋白脂质蛋白过早寡聚

获取原文
获取原文并翻译 | 示例
       

摘要

Pelizaeus-Merzbacher disease (PMD) is a dysmyelinating disease caused by mutations, deletions, or duplications of the proteolipid protein (PLP) gene. Mutant forms of PLP are retained in the endoplasmic reticulum (ER), and the resulting accumulation of mutant protein is thought to be a direct cause of oligodendrocyte cell death, which is the primary clinical feature of PMD. The molecular mechanisms underlying the toxicity of mutant PLP are however currently unknown. We report here that PMD-linked mutations of PLP are associated with the accelerated assembly of the protein into stable homooligomers that resemble mature, native PLP. Thus although WT PLP forms stable oligomers after an extended maturation period, most likely at the cell surface, mutant forms of PLP rapidly assemble into such oligomers at the ER. Using PLP mutants associated with diseases of varying severity, we show that the formation of stable oligomers correlates with the development of PMD. Based on these findings, we propose that the premature oligomerization of PLP in the ER of oligodendrocytes contributes to the pathology of PMD.
机译:Pelizaeus-Merzbacher病(PMD)是由蛋白脂蛋白(PLP)基因的突变,缺失或重复引起的髓鞘异常疾病。 PLP的突变形式保留在内质网(ER)中,并且突变蛋白的积累被认为是少突胶质细胞死亡的直接原因,这是PMD的主要临床特征。然而,目前尚不清楚突变体PLP毒性的潜在分子机制。我们在这里报告,PLP的PMD连锁突变与蛋白质加速组装成类似于成熟的天然PLP的稳定均聚物有关。因此,尽管WT PLP在延长的成熟期后形成稳定的寡聚物,最有可能在细胞表面,但是PLP的突变形式在ER处迅速组装成这种寡聚物。使用与不同严重程度的疾病相关的PLP突变体,我们表明稳定的寡聚物的形成与PMD的发展相关。基于这些发现,我们认为少突胶质细胞内质网中PLP的过早寡聚有助于PMD的病理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号